MIT Researchers Reprogram Immune Cells In-Body for Cancer and Autoimmune Therapies

MIT scientists have developed a new method to reprogram natural killer (NK) immune cells directly within the body using nanoparticles. Demonstrated in mouse models, this technique successfully eliminated tumors and reversed liver damage, offering a simpler and more cost-effective approach for immune therapies. The process involves delivering messenger RNA instructions to NK cells, enabling them to produce proteins that target diseased cells, potentially impacting cancer and autoimmune conditions like lymphoma and autoimmune hepatitis.